Notice of Availability of Government-Owned Inventions; Available for Licensing, 69144 [05-22516]

Download as PDF 69144 Federal Register / Vol. 70, No. 218 / Monday, November 14, 2005 / Notices • E-mail: Susan.Brown@uspto.gov. Include ‘‘0651–0045 copy request’’ in the subject line of the message. • Fax: 571–273–0112, marked to the attention of Susan Brown. • Mail: Susan K. Brown, Records Officer, Office of the Chief Information Officer, Office of Data Architecture and Services, Data Administration Division, U.S. Patent and Trademark Office, PO Box 1450, Alexandria, VA 22313–1450. Written comments and recommendations for the proposed information collection should be sent on or before December 14, 2005 to David Rostker, OMB Desk Officer, Room 10202, New Executive Office Building, 725 17th Street NW., Washington, DC 20503. Dated: November 7, 2005. Susan K. Brown, Records Officer, USPTO, Office of the Chief Information Officer,Office of Data Architecture and Services, Data Administration Division. [FR Doc. 05–22529 Filed 11–10–05; 8:45 am] BILLING CODE 3510–16–P DEPARTMENT OF DEFENSE Department of the Navy Notice of Availability of GovernmentOwned Inventions; Available for Licensing Department of the Navy, DOD. Notice. AGENCY: ACTION: SUMMARY: The Department of the Navy hereby gives notice of the availability of exclusive or partially exclusive licenses to practice worldwide under the following pending patents. Any license granted shall comply with 35 U.S.C. 209 and 37 CFR Part 404. Applications will be evaluated utilizing the following criteria: (1) Ability to manufacture and market the technology; (2) manufacturing and marketing ability; (3) time required to bring technology to market and production rate; (4) royalties; (5) technical capabilities; and (6) small business status. Patent application Serial Number 60/ 642,771 entitled ‘‘Fimbrial Adhesin as Vaccine Against Escherichia Coli’’ filed on January 11, 2005. The present invention relates to the field of inducing an immune response against diarrheagenic bacteria including enterotoxigenic Escherichia coli using bacterial fimbriae components. Patent application Serial Number 60/ 668,591 entitled ‘‘Recombinant Antigens for the Detection of Coxiella Burnetii’’ filed on April 6, 2005. The present invention relates to Coxiella VerDate Aug<31>2005 17:16 Nov 10, 2005 Jkt 208001 burnetii peptide antigens and recombinant DNA encoding the peptides. Patent application Serial Number 10/ 934,686, entitled ‘‘Hospital and Clinic Emergency Preparedness Optimization System’’ filed on September 3, 2004. The present invention relates to hospital and ambulatory clinic emergency management systems. Patent application Serial Number 60/ 683,787 entitled ‘‘Anti-Adhesin Based Passive Immunoprophylactic’’ filed on May 24, 2005. The present invention relates to a pharmaceutical useful in conferring passive protection against diarrhea caused by enterotoxigenic Esherichia coli. Patent application Serial Number 60/ 709,804 entitled ‘‘A Method for the Evaluation of Dengue Virus Therapeutic Agents’’ filed on August 22, 2005. The present invention relates to a method for evaluating the immunogenicity and efficacy of vaccine or drug formulations against dengue virus using a pig or porcine cells as models of infection and pathogenicity. Patent application Serial Number 60/ 715,578 entitled ‘‘Potts Reagent Alcohol-Solvent Extraction System’’ filed on September 12, 2005. This invention relates to a method for decontaminating alcohol so that it may be recycled in histology and other laboratory settings. Patent application serial Number, 60/ 722,086, entitled ‘‘Immunogenic Capsule Composition for Use as a Vaccine Against Campylobacter Jejuni’’ filed September 21, 2005. This invention relates to a pharmaceutical useful in conferring protection against diarrhea caused by Campylobacter jejuni and a method of administering said pharmaceutical. Patent application Serial Number 60/ 627,811 entitled ‘‘Diagnostic Assay for Rickettsial prowazekii Disease By Detection of Responsive Gene Expression’’ filed on November 10, 2004. The present invention relates to a method of diagnosing epidemic typhus caused by the bacteria Rickettsia prowazekii by analysis of modulation of host gene expression. The method contemplates the use of micro-array technology for the detection and analysis of gene up or down regulation in response to bacterial infection. DATES: Applications for an exclusive or partially exclusive license may be submitted at any time from the date of this notice. ADDRESSES: Submit application to the Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910– 7500. PO 00000 Frm 00012 Fmt 4703 Sfmt 4703 Dr. Charles Schlagel, Director, Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910–7500, telephone 301–319–7428 or e-mail at: schlagelc@nmrc.navy.mil. FOR FURTHER INFORMATION CONTACT: Dated: October 31, 2005. I.C. Le Moyne Jr., Lieutenant Commander, Judge Advocate General’s Corps, U.S. Navy, Alternate Federal Register Liaison Officer. [FR Doc. 05–22516 Filed 11–10–05; 8:45 am] BILLING CODE 3810–FF–P DEPARTMENT OF DEFENSE Department of the Navy Notice of Performance Review Board Membership Department of the Navy, DOD. Notice. AGENCY: ACTION: SUMMARY: Pursuant to 5 U.S.C. 4314(c)(4), the Department of the Navy (DON) announces the appointment of members to the DON’s numerous Senior Executive Service (SES) Performance Review Boards (PRBs). The purpose of the PRBs is to provide fair and impartial review of the annual SES performance appraisal prepared by the senior executive’s assigned rating officials; to make recommendations to authorizing officials regarding acceptance or modification of the performance rating; and to make recommendations for performance bonuses and basic pay increases. Composition of the specific PRBs will be determined on an ad hoc basis from among individuals listed below: ACKLEY, V. MR. ADAMS, P. MS. ALLES, R. BGEN BACHMANN, M. RDML BARBER III, A. MR. BARNUM, H. MR. BELAND, R. DR. BETRO, T. MR. BLAIR, A. MS. BONWICH, S. MR. BRANT, D. MR. BRENNAN, A. MS. BROTHERTON, A. MS. BURNS, J. RADM CALI, R. MR. CIESLAK, R. MR. COCKHRANE, E. MR. COOK, C. MR. COX, A. MR. CRABTREE, T. MR. CREEDON, C. MR. CWALINA, B. MR. DECKER, J. MS. DECKER, M. MR. E:\FR\FM\14NON1.SGM 14NON1

Agencies

[Federal Register Volume 70, Number 218 (Monday, November 14, 2005)]
[Notices]
[Page 69144]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-22516]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Availability of Government-Owned Inventions; Available 
for Licensing

AGENCY: Department of the Navy, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of the 
availability of exclusive or partially exclusive licenses to practice 
worldwide under the following pending patents. Any license granted 
shall comply with 35 U.S.C. 209 and 37 CFR Part 404. Applications will 
be evaluated utilizing the following criteria: (1) Ability to 
manufacture and market the technology; (2) manufacturing and marketing 
ability; (3) time required to bring technology to market and production 
rate; (4) royalties; (5) technical capabilities; and (6) small business 
status.
    Patent application Serial Number 60/642,771 entitled ``Fimbrial 
Adhesin as Vaccine Against Escherichia Coli'' filed on January 11, 
2005. The present invention relates to the field of inducing an immune 
response against diarrheagenic bacteria including enterotoxigenic 
Escherichia coli using bacterial fimbriae components.
    Patent application Serial Number 60/668,591 entitled ``Recombinant 
Antigens for the Detection of Coxiella Burnetii'' filed on April 6, 
2005. The present invention relates to Coxiella burnetii peptide 
antigens and recombinant DNA encoding the peptides.
    Patent application Serial Number 10/934,686, entitled ``Hospital 
and Clinic Emergency Preparedness Optimization System'' filed on 
September 3, 2004. The present invention relates to hospital and 
ambulatory clinic emergency management systems.
    Patent application Serial Number 60/683,787 entitled ``Anti-Adhesin 
Based Passive Immunoprophylactic'' filed on May 24, 2005. The present 
invention relates to a pharmaceutical useful in conferring passive 
protection against diarrhea caused by enterotoxigenic Esherichia coli.
    Patent application Serial Number 60/709,804 entitled ``A Method for 
the Evaluation of Dengue Virus Therapeutic Agents'' filed on August 22, 
2005. The present invention relates to a method for evaluating the 
immunogenicity and efficacy of vaccine or drug formulations against 
dengue virus using a pig or porcine cells as models of infection and 
pathogenicity.
    Patent application Serial Number 60/715,578 entitled ``Potts 
Reagent Alcohol-Solvent Extraction System'' filed on September 12, 
2005. This invention relates to a method for decontaminating alcohol so 
that it may be recycled in histology and other laboratory settings.
    Patent application serial Number, 60/722,086, entitled 
``Immunogenic Capsule Composition for Use as a Vaccine Against 
Campylobacter Jejuni'' filed September 21, 2005. This invention relates 
to a pharmaceutical useful in conferring protection against diarrhea 
caused by Campylobacter jejuni and a method of administering said 
pharmaceutical.
    Patent application Serial Number 60/627,811 entitled ``Diagnostic 
Assay for Rickettsial prowazekii Disease By Detection of Responsive 
Gene Expression'' filed on November 10, 2004. The present invention 
relates to a method of diagnosing epidemic typhus caused by the 
bacteria Rickettsia prowazekii by analysis of modulation of host gene 
expression. The method contemplates the use of micro-array technology 
for the detection and analysis of gene up or down regulation in 
response to bacterial infection.

DATES: Applications for an exclusive or partially exclusive license may 
be submitted at any time from the date of this notice.

ADDRESSES: Submit application to the Office of Technology Transfer, 
Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 
20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500, telephone 301-319-7428 or e-mail 
at: schlagelc@nmrc.navy.mil.

    Dated: October 31, 2005.
I.C. Le Moyne Jr.,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Alternate Federal Register Liaison Officer.
[FR Doc. 05-22516 Filed 11-10-05; 8:45 am]
BILLING CODE 3810-FF-P